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Current evidence-based research shows that pain in hospice patients is a growing problem. A 
gap in practice was identified as the current clinical practice guideline (CPG) in a hospice 
center in South Carolina was outdated and not being employed. A literature review revealed 
that updated CPGs provide better outcomes in pain management for end-of-life care. The 
project answered the practice-focused question: In the context of hospice, what are current 
evidence-based strategies for managing pain. The Stettler model and Kolcaba’s comfort 
theory guided the development of the CPG. Three nurse case managers and two physicians 
participated in the creation of CPG. The Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) was used to critically appraise the evidence selected 
for inclusion in the CPG. Only articles which scored a high or moderate on the GRADE scale 
were used in the final determination. Twenty scholarly articles were originally reviewed, and 
ten of those met the inclusion criteria. The updated CPG was developed using the Appraisal 
of Guidelines and Evaluation (AGREE) II tool consisting of six domains. Using the AGREE 
II Instrument and the scoring checklist, the CPG was reviewed by an expert panel of hospice 
physicians. Of the six domains, all domains exceeded the threshold of 70%, indicating 
acceptance of the domain. In addition, the final domain scored a 100%, which also indicated 
acceptance of the content of the CPG. It is recommended that the hospice nurses, clinicians, 
and practitioners implement this updated evidence-based pain management guideline to 
prescribe pain medications. This CPG has the potential to influence social change by 
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Section 1: Nature of the Project 
Introduction 
According to current evidence-based research, pain in hospice patients is a 
growing problem. According to the National Institute of Health (2021), more that 1.6 
million Americans received hospice services in 2014, and approximately 60% of them 
received these services at home. Hospice care emphasizes the deployment of an 
interdisciplinary care team to support patients and their family in comfort care, pain 
control, symptom management, and spiritual needs. Chi et al (2018) has found that the 
patients’ pain was undertreated in end-of-life care. For my project, I have updated the 
clinical practice guidelines (CPG) for pain management in a hospice center in South 
Carolina. The reason for this choice was that I have seen firsthand that not all patients 
receive adequate pain management that they deserve at end of life. By creating an 
updated CPG, I was able to assist physicians, nurse practitioners, and nurses in providing 
effective care for their patients. This guideline can serve as a means for all hospice 
facilities, home care services and in-patient units to follow the same practices for end-of-
life pain control.  
This CPG has the potential to influence social change by providing adequate pain 
management for patients at end of life. The CPG may generate a positive impact in the 
health care community that oversees hospice patients in the community. Stakeholders, 
which include physicians, nurse practitioners and clinical staff, will see positive 
improvements in their clinical practice when this CPG is implemented. Awareness of 
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basic tenets of pain management and access to practical references will now allow 
physicians and nurses to care effectively for their patients at the end of life.  
Problem Statement 
Statistics have shown that more than 50% of patients with terminal illness 
experience pain in the end-of-life stage (Hospice and Palliative Nurses Association, 
2011). In this practice setting, most patients are treated with the same pain management 
regimen when they are admitted for hospice service instead of being given orders based 
on their diagnosis. According to Booker and Haedtke (2016), evidence-based practice 
(EBP) is not widely used in hospice. Not only is this not patient-centered care, but for a 
patient to sit in pain waiting for new orders is unethical. There are many patients that are 
admitted to hospice every week. Some of these patients are dying from natural causes 
while some of them are suffering from other chronic diseases. Some of these diseases, 
such as metastatic cancers, can be debilitating.  
Pain in hospice patients is a growing problem. At a hospice center located in 
South Carolina, during the admission process, the same pain management regimen is 
prescribed for each patient regardless of diagnosis. CPG and EBP in this setting have not 
been employed for pain management. Thus, the practice problem that was the focus of 
this project was inadequate pain management at the end of life for patients receiving 
hospice service. The gap in nursing practice is evident at a hospice center in South 
Carolina where the CPG is outdated and not consistently followed. There is also no 
current CPG being used at this facility. EBP is also not being used for pain management 
in this setting. Professional care providers have identified that effective pain management 
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is an essential goal in providing end-of-life care (Chi et al, 2018). Despite this universally 
acknowledged goal, studies of terminally ill patient’s pain experiences consistently 
demonstrate that pain is not adequately managed (Herr, 2015).  
This doctoral project holds significance in nursing practice because it is the duty 
of clinicians to provide seamless pain management to all patients. . An evidence-based 
CPG is significant to increase the quality of life and pain management for patients who 
are transitioning into and currently receiving hospice care. 
Purpose 
There are multiple benefits that could be realized from a Doctor of Nursing 
Practice (DNP) scholar updating CPG for pain management. An updated CPG has the 
potential to improve the patient’s clinical course, improve patients’ quality of life, ease 
caregiver stress, and improve overall satisfaction. When a person is entering the last 
stages of life on hospice care, communication and shared decision-making with the dying 
person and those important to them should not have to be about pain management. Pain 
should be controlled from the day of admission to hospice care. The DNP prepared nurse, 
along with the clinical team, can use updated CPG to allow effective pain management to 
conform to their clinical diagnosis information assessed during admission, instead of 
using standing orders. Adequate pain management requires the intervention of all 
disciplines in a holistic approach. Unrelieved pain affects the patient's physical, 
psychological, social, and spiritual well-being (Chi et al, 2018)  
The gap in nursing practice was evident as the current CPG in a hospice office in 
South Carolina was outdated and not consistently followed. The updated CPG has 
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assisted in creating an evidence-based source to serve all providers and allow for more 
standardized pain management for the patients. 
This project answered the following practice focused question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain?’  
The updated CPG has the potential to impact social change by promoting positive patient 
outcomes. The overall goal was that patients will be more satisfied with pain 
management resulting in an increased quality of life. An updated CPG for patients has the 
potential to result in better outcomes, greater quality of life, and a smoother transition 
allowing for a more peaceful death. The benefit of providing pain medication based on 
the patient’s need will become apparent and more hospice and home health facilities may 
adopt this protocol. These changes have the potential for improving the quality of life for 
many patients and families. This updated CPG can help more than just one hospice 
facility. Should this CPG prove successful, by increasing patient pain management, this 
CPG can be shared with other facilities, promoting change in the hospice industry over 
time.  
The gap in nursing practice is evident as the current CPG in a hospice office in 
South Carolina, was outdated and not consistently followed. The challenge is to assist in 
adequate pain management for these patients at the end of life and ensure that they are all 
receiving adequate pain control. This updated CPG is the bridge that answers the practice 
question and narrows the gap in practice.  
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Nature of the Doctoral Project 
The literature suggested that updated CPG will provide better outcomes in pain 
management for end-of-life care (Max et al., 2011). The databases that I utilized for this 
CPG update included Google Scholar, the New England Journal of Medicine, CINAHL, 
PubMed, and Scopus. The year range that I searched was in the last 10 years, 2010-2020, 
because that provided the most up to date information. The keywords that I utilized in my 
search included pain management, hospice, end of life, pain control, and clinical practice 
guidelines. 
To research and produce this updated CPG, I referred to the Walden University 
Manual for clinical practice guideline development. This updated CPG was created for a 
local hospice office in South Carolina. This facility did not have updated CPG for pain 
management in place. I secured the approval of the facility administrator to use this 
facility and obtained approval from Walden’s Institutional Review Board (IRB). The 
facility medical director was interested in my clinical practice guideline ideas. There 
were three nurse case managers, two nurse practitioners and two physicians who had 
input for this CPG. This facility is currently undergoing policy and procedure changes 
related to implementing new electronic medical records, and this initiative serves as an 
opportunity to update the guidelines being used. The facility and implementation of the 
new medical records system can be defined as resources to support the practice problem.  
I developed the updated CPG using the Appraisal of Guidelines and Evaluation 
(AGREE) II tool. I obtained permission from the facility to collect input from the 
physicians, nurses, nurse practitioners, administrator, nurse managers, and other clinical 
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leaders and gain access to the current policies, data, and admission guidelines. I reviewed 
how the policies of the facility are developed and reviewed literature on the most current 
clinical trials, evidence-based articles, and other literature sources that could help in 
updating the hospice agency policy. This updated CPG is the bridge that answers the 
practice question and fills in the gap in practice. 
Significance 
The stakeholders for this updated CPG are the health care workers and health care 
providers. They are the nurses, physicians, nurse practitioners, physician assistants, and 
all other clinical staff who work in patient care. Additional stakeholders are the patients 
and family members. The effective management of pain is a time-honored goal of 
healthcare. From the time of Hippocrates to the present-day Code of Medical Ethics of 
the American Medical and Nursing Association, the assessment and management of a 
patient's pain has been the primary responsibility of every practitioner (Brockis,2011). 
According to Brockis (2011), effective pain management for a terminal patient 
population is possible according to medical experts, but there are several misconceptions 
about hospice and end-of-life care that persist in the medical field. Until these 
misconceptions and myths are refuted and physicians, nurses, patients, and their families 
are aware of the facts surrounding pain management in hospice, many patients will 
continue to experience end-of-life pain. Pain relief should always be the top priority in 
the treatment of hospice patients. Too much emphasis on treating other symptoms or 
trying to medically manage the underlying disease in hospice care can mean that 
terminally ill patients will have to wait needlessly to receive adequate pain management. 
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Allowing a person to endure pain when their pain can be managed and relieved violates 
the principle of beneficence because the provider is not preventing pain and therefore not 
acting in the best interest of the patient. It also violates the principle of nonmaleficence 
because it is causing harm and sometimes injury to the person.  
This project contributes to nursing practice. Despite advances in understanding 
pain physiology and available pharmacotherapies, many patients with terminal illnesses 
such as cancer report untreated or undertreated pain (Carlson, 2017). Hospice programs 
are geared towards providing relief from pain, both physical and emotional for the patient 
and their family. The purpose behind hospice care is to make the time that hospice 
patients have left as comfortable, dignified, and enjoyable as possible and to allow them 
the comfort they need to die with dignity. The goal of hospice care is not to prolong life 
or to medically manage patients’ chronic conditions, the goal is to provide patients with a 
high-quality end of life.  
Other stakeholders are the patients and their families as pain management affects 
them just as it affects the clinician. Pain management should remain a high priority so 
that higher quality of life can be enjoyed by the patients on hospice services. Although 
death is inevitable for everyone, it should not have to be painful when there is relief 
available. Many patients experience significant pain in the final months of life. In 
addition to wanting to preserve as much quality of life as possible, most patients express 
a preference to die outside of acute care settings, and a key element to achieving these 
goals is adequate pain management and being at home with their families. 
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This updated CPG has transferability to many other locations, not just the facility 
for which it was created. This updated CPG can be used as a guide in other hospice 
offices, home health agencies, inpatient hospice units, and in physician offices. This CPG 
has the potential to influence social change by providing effective pain management to 
patients at the end of life. The CPG has the potential to generate a positive impact to the 
health care community that oversees hospice patients in the community. Stakeholders, 
who are patients, families, and staff, have seen positive improvements in their care since 
this CPG has been implemented. 
Summary 
In Section 1,I discussed the problem statement, project purpose, nature of the 
problem, gap in practice, and significance of the project. I showed which stakeholders 
have benefited from an updated CPG and how it has impacted social change. In Section 
2, I discuss potential models and theories, as well as the relevance to nursing practice and 
my role as the DNP student. I also introduce the project team and discuss their role in this 
DNP project.  
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Section 2: Background and Context 
Introduction 
The gap in nursing practice at this hospice office in South Carolina is the lack of a 
CPG addressing pain management in patients admitted for end-of-life care. More 
specifically, there is no CPG used in this facility. EBP is also not being used for pain 
management in this setting. Thus, this project answered the following practice focused 
question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain?  
The updated CPG has the potential to impact social change by promoting positive patient 
outcomes. The purpose of this DNP project was to develop a clinical practice guideline 
update for controlling pain in hospice patients receiving end-of-life care. The goal of this 
project was to provide the clinical site with a clinical practice guideline that would 
support the clinical teams’ efforts to manage pain effectively based on the diagnosis of 
the patient. In this section, I discuss the Stettler model, relevance of the project to nursing 
practice, the local background and context, and my role as the DNP student. 
Concepts, Models, and Theories 
This project utilized the Stettler model (Coyne et al., 2018). The Stettler model 
enables practitioners to assess how research findings and other needed evidence are 
implemented into clinical practice. This model aids examination of how to utilize 
evidence to create the change needed to foster patient-centered care. This model has five 
phases to follow. Phase 1 consists of identifying the need for change. Phase 2 validates 
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the evidence and quality of the evidence to deem whether there is a good fit in relation to 
the project. In Phase 3, the evidence for change is summarized and evaluated. The project 
team determined whether the evidence was acceptable to be applied practice. In Phase 4, 
The project team developed the “how to” for implementation and identified the practice 
implications to justify creating the change. Finally, in Phase 5, the team identified the 
expected outcomes of implementing the project and will then determine whether the 
goals of the EBP were achieved (see Coyne et al, 2018). The team used all four of the 
following nursing concepts for this CPG update: the person, environment, health, and 
nursing (Nikfarid et al, 2018). 
The National Institute of Health (2021) surveyed 348 patients in 16 hospice 
settings. The researchers found that 76% of these patients experienced pain, with frequent 
and severe symptoms more prominent in patients with less than 15-day stays. This is a 
concern given reports that suggest 70%–90% of all hospice patients both at home and in 
facilities could achieve pain relief with the implementation of existing evidence and CPG 
(Chi et al., 2018). 
Next, I define some of the terminology used in this DNP project: 
Hospice patient: A patient who is in the last 6 months of life and is admitted to 
hospice care for end-of-life management (Carlson et al., 2017). 
Nurse case manager: A registered nurse who cares for admitted hospice patients 
in their home or at a facility (Scott-Findlay, 2006).  
End of life:The last 6 months of a patient’s life. A patient is in end of life when 
their prognosis is less than 6 months (Carlson et al., 2017). 
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Admission standing orders: Blanket standing orders used during a patient 
admission to start care (Munasinghe et al., 2011).  
Palliative care: Patient and family-centered care that optimizes quality of life by 
anticipating, preventing, and treating suffering (Carlson et al, 2017).  
End-of-life care: The term used to describe the support and health care given 
during the time surrounding death (Brockis, 2011).  
The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument 
(Appendix A) is a widely used standard for assessing the methodological quality of 
practice guidelines (www.agreetrust.org) This tool was used in this CPG update to assess 
and evaluate the quality of the evidence. The AGREE instrument, developed by the 
AGREE Enterprise, is a quantitative method for evaluating CPGs. The AGREE 
instrument is a tool designed primarily to help guide developers and users in assessing the 
methodological quality of guidelines.  
Kolcaba’s comfort theory was used to guide the development of the CPG for the 
DNP-prepared nurse (Coelho et al., 2016). The theory is considered a middle range 
theory that has the potential to direct the work and thinking of all healthcare providers. 
According to Kolcaba’s theory, patients can be defined as individuals, families, 
institutions, or communities in need of health care. (Krinsky et al, 2014). The 
environment is any aspect of the patient, family, or institutional surroundings that can be 
manipulated by a nurse or loved one to enhance comfort. Health is optimal functioning in 
the patient, as defined by the patient, group, family, or community (Krinsky et al., 2014).  
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Relevance to Nursing Practice 
The broader issue in nursing practice is that not all patients are getting the same 
level of pain relief in hospice care. Patients deserve ethical treatment, and this includes 
pain relief. The treatment of pain is an ethical obligation. Health science schools, 
especially medical training institutions such as medical schools and nursing schools, have 
the duty to teach pain management in a comprehensive fashion. The regulatory measures 
taught in these schools, which limit access for patients to opioid treatments, are unethical 
and should be reconsidered (Chi et al, 2018). 
According to Carvalho et al. (2018), there is evidence that patients often suffer 
from uncontrolled and unnecessary pain. This is inconsistent with the leges artis, and its 
practical implications merit a bioethical analysis. A research article written by Herr et al. 
(2010) stated that one of the goals of hospice care is a pain-free death, which is important 
to everyone involved in the experience. Although pain outcomes are better in hospice 
care patients than nonhospice settings, there are gaps and inconsistencies in hospice 
practices of effective assessment and management of pain, which was the basis for 
updating the CPG (Chi, 2018). 
The CPG that most hospice facilities use was last published in 2018, and it was 
published by the National Coalition for Hospice and Palliative Care National Consensus 
Project for Quality Palliative Care. In that CPG, the authors stated that pain and practical 
needs are systematically addressed with the patient and family throughout the continuum 
of care. If present, any conditions are treated based upon current evidence and with 
consideration of cultural aspects of care. However, the CPG fails to address the gap in 
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pain management between patients with different diagnoses (National Coalition for 
Hospice and Palliative Care National Consensus Project for Quality Palliative Care, 
2018).  
According to current evidence-based research, pain in hospice patients is a 
growing problem. As reported by the National Institute of Health (2019), more that 1.6 
million Americans received hospice services in 2014, and approximately 60% of them 
received these services at home. Hospice care emphasizes the deployment of an 
interdisciplinary care team to support patients and their family with comfort care, pain 
control, symptom management, and spiritual needs. Chi et al (2018) has found that the 
patients’ pain was undertreated in end-of-life care.  
The National Hospice and Palliative Care Association (Hospice and Palliative 
Nurses Association, 2011) surveyed 348 patients in 16 hospice settings. The researchers 
found that 76% of these patients experienced pain, with frequent and severe symptoms 
more prominent in patients with less than 15-day stays. This is a concern given reports 
that suggest 70%–90% of all hospice patients both at home and in facilities could achieve 
pain relief with the implementation of existing evidence and CPG (Chi et al., 2018). 
In October 2015, the American Society for Pain Management created a guide for 
end-of-life pain management in hospice (Herr, 2015). Herr (2015) noted that in a study of 
elderly nursing home residents who were enrolled in hospice care, the prevalence of pain 
was close to 60%. Based on findings of a meta-analysis of 52 studies spanning 40 years, 
Brockis (2011) also found that 64% of patients with advanced cancer have pain. One-
third of all patients who were reviewed in these studies rated their pain as moderate or 
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severe on a pain scale. This finding should be found as unacceptable (Hospice and 
Palliative Nurses Association, 2011). Despite these findings, this clinical update did not 
address the gap in pain management between patients who had different diagnoses, and at 
this facility patients were still being admitted with the recommendation of pain 
management standing orders on admission. 
Local Background and Context 
This updated CPG has the potential to impact social change by promoting positive 
patient outcomes. Families will be more satisfied with the care their loved ones received. 
Hospitals will be more willing to send referrals to a facility by knowing there is more 
focus on end-of-life pain management. Patients will have better outcomes, greater quality 
of life and a smoother transition allowing for a more peaceful death. The benefit has the 
potential to provide pain medication based on diagnosis, and as the success of the CPG 
becomes apparent, more hospice and home health facilities will adopt this protocol. This 
can increase the quality of life for many patients and families. A current clinical guideline 
can help more than just one hospice facility. Once this CPG has proven successful, this 
CPG can be shared with other facilities, promoting change in the hospice industry. 
This updated CPG was created using a local hospice office in South Carolina. 
This office does not currently follow any CPG for its pain management protocols. I 
secured the approval of the facility administrator to use this facility. The facility medical 
director was very interested in my clinical practice guideline ideas. There were three 
nurse case managers, two nurse practitioners, and two physicians who had input for this 
CPG. This facility provided an opportunity to implement my DNP project and to create a 
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CPG. This facility was undergoing policy and procedure changes related to implementing 
new electronic medical records, and thus this was a perfect time to update the guidelines 
being used. This facility was a perfect match to plan the CPG guidelines. The updated 
CPG aligns with the facility’s mission statement: “Our goal is to offer comfort and loving 
care that allows a patient to feel like family and have the best last days of their life 
possible.” Updating the CPG has allowed the facility’s mission to come alive through 
reducing the burden of pain and increasing the quality of life.  
Federal regulations Condition of participation: Initial and comprehensive 
assessment of the patient, 42 CFR Section 418.54 states that: “The medical director … 
assumes overall responsibility for the medical component of the hospice’s patient care 
program.” This would include adequate pain management for all patients admitted to 
service. Federal article 42 CFR Section 418.50 (2015) states: “A hospice must make 
drugs routinely available on a 24-hour basis, to include pain management medications.” 
This updated CPG would assist in ensuring the facilities are federally compliant with 
these regulations. Currently there are no state regulations that would apply to this updated 
CPG. 
Role of the Doctor of Nursing Practice Student 
The DNP nurse has a vested interest in the clinical course of each patient. In 
hospice care, this includes adequate and timely pain control for all. Being a major 
contributor to the clinical team, the DNP nurse oversees the advanced planning and 
implementation of guidelines and policy, for each patient under their care. The DNP 
student nurse has created an updated clinical guideline, using EBP, new clinical models 
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for pain management in the hospice patient. The DNP practice prepared nurse has 
changed the clinical guideline to allow prescription pain medication to be based on 
clinical diagnosis information on admission instead of standing orders. Good pain and 
symptom management require the intervention of all disciplines in a holistic approach. 
Unrelieved pain affects the patient's physical, psychological, social, and spiritual well-
being. The DNP student has created, from the best evidence-based articles, newly 
updated guideline which can assist the care team in bridging the gap in pain management 
for hospice patients. With the assistance of the facility medical director, nurse 
practitioners, nursing staff and support staff, the updated CPG was made possible through 
collaboration, and development.  
This updated CPG has the potential for transferability as, this updated CPG may 
be utilized in many other hospice facilities, not just the facility where it was created. This 
updated CPG can be used in other hospice offices, home health locations, inpatient 
hospice units and in physician offices as a guide. Despite advances in understanding pain 
physiology and available pharmacotherapies, many patients with terminal illnesses, such 
as cancer, report untreated or undertreated pain, therefore this is the basis for this updated 
CPG (Booker & Haedtke, 2016).  
Role of the Project Team 
The health care staff that are responsible for assisting this nurse in the creation of 
this updated CPG were the physicians at the local hospice office, the nurse case 
managers, the nurse practitioners, the facility educators, my clinical mentor, and my 
preceptor for my clinical courses. The facility medical director served as the expert on 
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this panel. The staff are a part of the project team by means of assisting with evidence-
based clinical research, providing input on current policy and procedures for hospice 
patients, and by providing the current guidelines that the office follows for pain 
management. The DNP student has utilized the DNP essentials to assist in these change 
actions and implementations (Zaccagnini & White, 2015). 
The team was provided with the background information, including current CPG, 
evidence-based methods and literature associated with the project, to review. They then 
had the opportunity to share their experiences, knowledge, expertise, and relevant 
information on how it may pertain to the CPG. The timeline between presenting the 
materials and gathering the data from the team was 14 days. This timeline gave each 
member time to process the data, review all the literature and provide feedback.  
The medical director at this hospice facility has been a hospice medical director 
for twenty years and has extensive knowledge in pain management, EBP implementation 
and clinical guidelines. The registered nurse case managers have been caring for hospice 
patients for multiple years and have seen the guidelines in use in the field and can attest 
to the fact that they do not satisfy the need for pain management for the patients we serve. 
The nurse practitioners in the office are hospice certified and have the highest level of 
education and training in the art of hospice care. They understood the need for updated 
CPG firsthand and provided information on how and when the changes should be made. 
The role of these essential staff was for support, information, policy and 
procedure development, evidence-based clinical needs assessment and implementation of 
current CPG in the line of duty. By working with the previous CPGs, these staff members 
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were aware of the changes that need to be made for the best care for a patient’s pain. All 
these team members were excited to have been a part of the change that can occur from 
an updated CPG. 
Summary 
In section two, we have discussed the concepts, models, and theories guiding the 
project, relevance of the practice problem to nursing practice, local background and 
context, role of the DNP student and the project team This was a critical component of 
the CPG, as the input from the clinical team, who has the hands-on experience, was 
extremely beneficial when reviewing EBP guidelines. In section three, we focus on the 
practice- focused question, sources of evidence, evidence generated for the doctoral 
project and procedures that were used for the collection and analysis of evidence. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
At a hospice office located in South Carolina, during the admission process, the 
same pain management treatments are prescribed for everyone, regardless of diagnosis. 
CPG and EBP in this setting have not been employed for pain management. This project 
answered the following practice-focused question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain? 
In Section 3, I focus on the practice focused question, sources of evidence, 
evidence generated for the doctorate project, and procedures that I used for the collection 
and analysis of evidence. In hospice care, most patients are treated with the same pain 
management regimen, and their pain is not effectively controlled (Booker & Haedtke, 
2016). According to Booker and Haedtke (2016), EBP is not widely used in hospice. Not 
only is this not patient-centered, but for a patient to be in pain at the end of life is 
unethical. According to current evidence-based research, pain in hospice patients is a 
growing problem (Chi et al., 2018). 
Practice-Focused Question 
This project answered the question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain? 
The gap in nursing practice was evident as current clinical guidelines and EBP 
had not been updated properly for pain management in this setting. More specifically, the 
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gap in practice that this CPG will correct is that not all patients are receiving adequate 
end-of-life pain management. The challenge is to assist in achieving adequate pain 
management for patients at the end of life to ensure that they are receiving effective pain 
management based on individual need. This updated CPG improves the patient’s clinical 
course, improves patient quality of life, eases caregiver stress, and improves overall 
satisfaction in providing services for the patient and family. This will be done by filling a 
void in the current practice for addressing pain management in this facility. When a 
person is entering the last days of life in hospice care, communication, and shared 
decision-making with the dying person and those important to them should not have to be 
about pain management. Pain management, pain medicine, pain control or alleviation is a 
branch of medicine that uses an interdisciplinary approach for easing suffering and 
improving the quality of life of those living with pain (Raffaeli & Arnaudo, 2017). 
I collaborated in developing updated CPG using evidence-based research and 
helped create new clinical models for pain management in the hospice patient population. 
I updated the clinical guidelines to allow prescription pain medication to be based on the 
clinical diagnosis information from admission instead of using standing orders. Effective 
pain management requires the intervention of all disciplines in a holistic approach. 
Unrelieved pain affects the patient's physical, psychological, social, and spiritual well-
being. According to the National Institute of Health (2021), more that 1.6 million 
Americans received hospice services in 2014, and approximately 60% of them received 
these services at home. Hospice care emphasizes the deployment of an interdisciplinary 
care team to support patients and their family in comfort care, pain control, symptom 
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management, and spiritual needs. Chi et al (2018) has found that the patients’ pain was 
undertreated in end-of-life care. 
Sources of Evidence 
The literature suggested that updated CPG will provide better outcomes in pain 
management for end-of-life care (Herr et al., 2015). An updated CPG was produced by 
accessing major databases including Google Scholar, the New England Journal of 
Medicine, PubMed, CINAHL, and Scopus. Specific sources of evidence that were 
searched included books, dissertations, theses, peer-reviewed journals, and random 
controlled trials. The year range that I researched were the last 10 years, 2010-2020. The 
reason I used this time frame is that it provided the most up to date evidence-based 
information. The keywords that I utilized in my search included pain management, 
hospice, end of life, pain control, and clinical practice guidelines. Along with a thorough 
literature review, I also reviewed and analyzed past CPGs in the hospice pain 
management setting. 
In the past 10 years, there have been no solid foundational updates in pain 
management for end-of-life care. While there are many articles and sources that address 
the need for pain management at end of life, there have been few published guidelines. 
An article published by Herr et al. (2015) states that the most important goal of hospice 
care is a pain-free death. Although pain outcomes are managed more effectively in 
hospice than nonhospice settings, there are gaps and inconsistencies in hospice practices 
of effective assessment and management of pain (Raffaeli & Arnaudo, 2017). These 
inconsistencies are associated with facilities not using CPG in managing pain. 
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Implementation of CPG would help update health care providers on effective pain 
management strategies in the hospice population. Even high-quality hospice care fails to 
eliminate pain in up to 75% of cases (Chi et al., 2018). This lapse in practice is due to 
outdated EBP and inconsistencies in using clinical guidelines. For older adults with 
cancer, the percent of patients receiving effective pain management without a diagnosis 
of cancer remains low (Chi et al., 2018). The degree of variability in pain management 
practices are evidenced by low adherence to some pain related EBPs. Those variabilities 
encountered among the research suggest other processes of care may lack uniformity.  
The relationship between the evidence and the need for updated CPGs are shown 
in the most recent 10 years. Medical science is forever changing; this means that an 
article published more than 10 years ago may now be obsolete. I wanted to keep this 
literature review current by using the most up to date science and evidence. The purpose 
of this evidence was to view where the gap in practice was in pain management so that I 
could create the most current CPG, one that addressed the practice question. By 
collecting data, the project team able to see the exact methodology of pain management 
currently in use, how pain regimens are determined based on standing orders, and how 
best to implement changes to increase pain control for hospice patients. Collecting and 
analyzing this evidence was critical in providing the best up to date information available 
for current EBP. Utilizing this evidence was paramount in creating an effective CPG that 
addressed the practice problem.  
Approval was received from the facility and from Walden’s IRB (approval 
number 08-11-21-024132), and evidence-based findings on current approaches for 
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managing pain at end of life were collected and analyzed from the medical directors, 
nurse practitioners, and other members of the health care team. Collection and analysis of 
this evidence provided the most appropriate strategy to address the practice focused 
question.  
Analysis and Synthesis 
As stated previously, the practice problem occurring in this clinical setting is pain 
management orders that are outdated and underemployed for terminally ill patients 
admitted for hospice care. Adopting a CPG as an approach, this DNP project was 
designed to answer the following practice-focused question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain?  
Major steps for developing the CPG included selection of current evidence, searching the 
literature, critically appraising and synthesizing the literature, and developing the CPG. 
Following development of the CPG, an expert panel was asked to review and score the 
CPG. Using feedback from the panel, the CPG was revised as needed. The final steps in 
developing the CPG included seeking key stakeholder input and finalization of the CPG. 
The content that follows provides details of the procedure that was used to analyze and 
synthesize evidence that was utilized to answer the practice-focus question. 
Collected data was tracked, organized, recorded, and analyzed using Microsoft 
Word, Microsoft Excel, Fulcrum, GRADE , AGREE II, and Mum’s Hummingbird 
software. Maintaining the integrity and safety of the evidence was paramount to the 
investigation. By precisely using the data integrity software suite Fulcrum, the team was 
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sure that the integrity of the evidence collected was thoroughly examined for outliers and 
missing information. These systems were double and triple checked for accuracy, 
integrity, and completeness. Data analysis was conducted using the AGREE II instrument 
(http://www.agreetrust.org); I analyzed each of the six domain scores and overall 
assessment of the clinical practice guideline. After this step was completed, the final 
score was calculated and reported.  
The AGREE instrument evaluates the process of practice guideline development 
and the quality of reporting. The AGREE tool (Appendix A) comprises 23 items (each 
with specific reporting criteria) in six domains: Scope and Purpose (Items 1-3), 
Stakeholder Involvement (Items 4-6), Rigor of Development (Items 7-14), Clarity of 
Presentation (Items 15-17), Applicability (Items 18-21), and Editorial Independence 
(Items 22-23). An additional two-question “overall guideline assessment” asks the expert 
panelist to judge the overall quality of the guideline and indicate whether the guideline 
should be recommended for clinical practice. The original AGREE instrument was 
developed in 2003 and refined resulting in the AGREE II instrument. Authors of practice 
guidelines can use the AGREE Reporting Checklist prospectively during the drafting and 
final editing stage to ensure that all necessary information is included and retrospectively 
after the guideline is completed as a quality assurance step. The AGREE Reporting 
Checklist (Appendix C) is sufficiently universal that it can be used by practice guideline 
stakeholders regardless of the more specific protocols or methods used to support the 
development of the guidelines. 
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GRADE is a transparent framework for developing and presenting summaries of 
evidence and provides a systematic approach for making clinical practice 
recommendations (Guyatt et al, 2008). It is the most widely adopted tool for grading the 
quality of evidence and for making recommendations, with over 100 educational 
organizations worldwide officially endorsing GRADE. GRADE has four levels of 
evidence, also known as certainty in evidence or quality of evidence: very low, low, 
moderate, and high (Table 1). 
Table 1 
Grade Certainty Ratings 
Very low The true effect is probably markedly different from the 
estimated effect 
Low The true effect might be markedly different from the estimated 
effect 
Moderate The authors believe that the true effect is probably close to the 
estimated effect 
High  The authors have a lot of confidence that the true effect is 
similar to the estimated effect 
 
Evidence from randomized controlled trials starts at high quality and, because of 
residual confounding, evidence that includes observational data starts at low quality. The 
Grade of the evidence is included in the literature review in Appendix D. 
There are different ways to classify studies that evaluate health care services. One 
such scheme distinguishes between process and outcomes studies (Chi,2018). Process 
studies are what science uses to assess whether the medical care encounters constitute 
quality care. Analysis will be performed on all the data, to track and trend all the 
information. This analysis helped us determine where current CPGs have failed, and how 
26 
 
an updated CPG can be more beneficial, which will answer the practice focused question. 
The DNP student has updated the CPG based on current evidence. After the clinical 
practice guideline was updated, the student sought consent from panelists. The consent 
asked for them to participate on the expert panel to provide feedback and 
recommendations. These experts included the facility medical director and nurse 
practitioners, who will be the most involved in the hospice patient’s pain management 
protocols.  
Selection of Evidence and Searching the Literature 
A literature search was conducted to locate current evidence for managing pain in 
the hospice population. Using the assistance of the university library liaison, major 
databases were searched including Google Scholar, PubMed, CINAHL, EMBASE, 
TOXNET and Cochrane Library. Evidence selected for the CPG was analyzed, 
organized, and recorded using a literature summary table (Table 2, Appendix D) 
Table 2 
Literature Summary Table Example 
      Author / 





Intervention  Findings  
 
 
    
 
 





Critical Appraisal of the Evidence from the Literature 
GRADE was used to critically appraise the evidence selected for inclusion in the 
CPG. GRADE is a transparent framework for developing and presenting summaries of 
evidence and provides a systematic approach for making clinical practice 
recommendations. It is the most widely adopted tool for grading the quality of evidence 
and for making recommendations. I have also followed Walden Universities guideline for 
CPG development. 
Synthesis of Evidence from the Literature 
Synthesis of the evidence was presented to expert panelists using a concept map, 
literature table and narrative summary explaining current evidence in managing pain in 
the hospice population.  
Development of the Clinical Practice Guideline 
The CPG includes recommendations that were based on evidence from a rigorous 
systematic review and synthesis of the published medical literature found for this topic. 
The clinical practice guideline was developed based on an analysis and synthesis of the 
literature on current practices for managing pain in the hospice population. Once all the 
literature had been reviewed, and the expert panel consulted, the updated CPG was 
created and then evaluated and approved by the experts and the stakeholders.  
Expert Panel Review 
Using the AGREE II Instrument (Appendix A), and the AGREE II scoring 
checklist (Appendix C) the CPG was reviewed by an expert panel. The panel scored the 
CPG by reviewing all the data and giving a rating of very low, low, moderate, or high on 
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the usefulness and completeness of the CPG via GRADE. The expert panel was asked if 
the CPG meets their expectations, does not meet expectations, or exceeds expectations. 
The expert panel was then be asked if they will be comfortable or not comfortable 
implementing the CPG into their practice. This process helped the writer determine if the 
CPG meets the needs and expectations of the stakeholders and expert panelists. At the 
completion of the DNP project, an evaluation was performed. The summary of the 
evaluation consisted of the AGREE II scores, and recommendations for use and 
implementation. This data was presented to the content experts for evaluation and 
provided to the facility stakeholders for review and implementation consideration.  
Stakeholder Input 
The stakeholders for this updated CPG were the health care workers and health 
care providers. These individuals were the nurses, physicians, nurse practitioners, 
physician assistants and all other clinical staff that work in patient care. Input on this 
updated CPG was obtained from the clinical team, (nurses, nurse practitioners, aids, and 
support staff) who assisted in advising on the necessity and usefulness of the proposed 
update. These front-line staff are the individuals who are hands on with the patients and 
see the need for change daily. The input from these staff members was paramount to the 
success of the updated CPG. Input and recommendations by these teams provided 
assurance that patient needs are met. These staff members know from personal 
experience, clinical practice and from patient and family input, exactly what is needed to 
provide effective pain management. 
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Protection of Participants 
After I obtained proposal approval, I submitted the project to Walden’s IRB for 
review and approved. The Walden IRB role was to review the project for any potential 
human subject violations or any breaches in data collection in accordance with Walden’s 
regulations. Following the approval from Walden’s IRB, the project was submitted to the 
project site for review and approval. The role of the project site was to ensure the project 
complies with the organization’s research requirements and human subject protections.  
Finalization of Clinical Practice Guideline 
This section summarizes the development process by reviewing key literature 
from other CPG developers. It focused on key methods and challenges specific to CPGs 
for integration by using analysis and synthesis to provide a powerful update to this CPG 
development. The guideline development process identified, together with new 
approaches, incorporated evidence-based methodology and provided more up to date 
information for hospice patients. It is also believed that quality of life issues based on 
pain levels were not fully addressed in prior guidelines. Information to finalize the CPG 
was used from shared experiences and coping strategies that empower nurses to take 
charge of their patient’s pain management and become equal partners with other care 
providers. 
Summary 
In section three, we reviewed the practice focused question and sources of 
evidence. We described the procedures we will be using for tracking and processing the 
data, protecting the integrity of the evidence, and processing the data. We talked about 
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analysis procedures and how they helped to answer the practice focused question. Section 
three also included details of the systems for data analysis and synthesis. Procedures for 
collection and analysis of evidence to answer the practice focused question were 
discussed. Section three also presented plans to address human subject protection. In 
section four, we will discuss findings and implications, contributions of the doctoral 
team, strengths and limitations, recommendations, and contributions of this project.  
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Section 4: Findings and Recommendations 
Introduction 
The local problem that was addressed in this project was that hospice patients’ 
pain management was not being met using the previous protocols. This was prohibiting 
the clinical staff from providing the best end-of-life care possible. Updated standardized 
guidelines on end-of-life pain management will bridge the gap to improve pain control. 
The newly updated CPG serves to answer the practice focused question:  
PFQ: In the context of hospice, what are current evidence-based strategies for 
managing pain? 
The gap in nursing practice was addressed by creating an updated CPG for hospice 
clinicians to use for better pain management during hospice care. This updated CPG will 
provide prescribing information to providers so they can provide quality pain 
management and treatment to hospice patients. This will provide a better standard of care 
as well as increased quality of life and improved patient outcomes.  
Using Walden’s library, I utilized peer reviewed articles from Cochrane Database, 
PubMed, Google Scholar, PubMed, CINAHL, EMBASE, and Medline to address the gap 
in practice and update the CPG. This review was exhaustive and critical for organizing 
the evidence for the updated CPG. Following the AGREE II guidelines, I was able to 
create the updated CPG for end-of-life pain management for hospice patients. The CPG 
was assessed by an expert panel consisting of five clinicians, who used the AGREE II 
website. The data was then scored for each of the domains. These numbers were then 
imported confidentially, hiding any identifying characteristics and maintaining the 
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experts’ confidentiality. In section 4, I discuss the findings, strengths, and limitations of 
this project.  
Findings and Implications 
The literature that were applicable were all graded using the GRADE 
methodology (Table 1) to evaluate the strength and quality of support to the 
recommendations in the guideline. The GRADE methodology applies a cohesive and 
organized approach, which is used to determine the strength and direction of 
recommendations. The strength of each piece of evidence was assigned a grading level of 
very low, low, moderate, and high. Each piece of evidence was synthesized into an 
evidence table to manage the evidence The guideline was created using the graded 
evidence that supported the recommendations. Only articles that scored as high or 
moderate on the GRADE scale were used in the final determination for this updated 
CPG. Articles that scored a level of low or very low were excluded. A literature table 
with a GRADE score for each article is in Appendix D. 
Five expert panelists used the AGREE II tool to provide me with an evaluation of 
the updated CPG (Appendix E). The results of the tool showed data from each of the 23 
items, as well as six individual domains with a tabulated percentage within each of the 
domains. Per the AGREE II tool, Any of the domains that scored higher than 50% were 
considered to be acceptable; however any of the domains that scored below 75% should 
be further reviewed. 
• Domain I, Scope and Practice, scored a 97%. Domain 1 addressed the CPG 
scope and overall focus. The population for this area was admitted hospice 
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patients. Evaluator 2 suggested changing the verbiage to include patients 
being evaluated for admission and include them in the scope as well. This was 
fitting as most of the orders are used on admission. 
• Domain II, Stakeholder Involvement, scored a 98%. The expert panel was 
pleased that the guidelines utilized all the appropriate disciplines, such as 
physicians, nurse practitioners, physician assistants, and advanced practice 
nurses who can prescribe medications. The panel agreed that the stakeholder 
involvement domain was clearly defined and that the criteria were met.  
• Domain III, Rigor of Development, scored a 97%. This domain focused on the 
methods that were utilized to search for evidence, the criteria for including 
evidence, strengths and limitations of the evidence, and the procedures used to 
update the guideline. The expert panel agreed that there was enough 
supporting evidence and that the literature review was adequate.  
• Domain IV, Clarity of Presentation, scored a 94%. This domain addressed the 
clarity of the presentation, which included recommendations and management 
of the health issue.  
• Domain V, Applicability, scored a 100%. This domain addressed the 
applicability of the guideline, which focused on adequate pain management 
for hospice patients using the patient’s diagnosis as a guide instead of standing 
orders. The expert panel agreed that this is a very important issue, which 
needed to be addressed. The expert panel commented that by using this 
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guideline for starts of care, pain management can be controlled from the 
beginning and the patient’s quality of life improved overall.  
• Domain VI, Editorial Independence, scored a 95%. There were no funding 
requirements for this project. This showed that there were no other views that 
would have had competing interest in this guideline. The expert panel agreed 
that “funding bodies should not have any influence on guideline 
developments.” 
• The overall domain scored was 100%, a usable CPG. In the overall guideline 
assessment portion, the expert panel agreed across the board, with all 
evaluators agreeing that they would recommend this CPG. Panelists noted that 
the guidelines were of “high quality” and come at a time where they could not 
be more needed in the hospice community. The panel agreed that these 
guidelines would increase patients’ quality of life, improve pain management, 
advance positive patient and family outcomes, and reduce the stress on the 
clinical team. Considering that these guidelines come with no additional cost 
to the facilities or community, there are no financial burdens to deter the 





















1 21 20 56 21 28 14 7 
2 21 21 54 20 28 13 7 
3 20 21 55 19 28 13 7 
4 20 21 54 19 28 13 7 
5 20 20 55 20 28 14 7 
Percentage 97% 98% 97% 94% 100% 95% 100% 
Note. Threshold for guideline quality is 70% or above.  
I was gratified to see such high scoring results for this updated CPG from the 
expert panel. None of the expert panelists asked for additional information or 
clarification. All commented that it was a well thought out and presented CPG and very 
usable in the practice setting. When presenting the results and discussing all the scores 
with the experts, they were impressed with the thoroughness, thoughtfulness, ethical 
consideration, and quality of life improvement that would render the updated CPG 
beneficial. No changes or updates were recommended by any of the experts during the 
review. All expert panelists strongly encouraged that the updated CPG be implemented as 
soon as possible and shared with the other facilities in the community and throughout the 
company. They are hopeful for a streamlined implementation with continuity of care 
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throughout the different levels of the health system. The feedback from all other end 
users of the CPG were that overall, this was a very well written and beneficial CPG and 
will indeed assist in an increased quality of life for the hospice patient due to improved 
pain management. The updated CPG will give the clinicians the tools to ensure that 
correct pain medications are ordered on admission based on clinical diagnosis and not 
standing orders. Admissions of different diagnoses require different care. As shown in the 
chart below, cancer patients make up 65% of admissions, heart disease 20%, dementia 
10%, and other natural causes 5%. Each of these different types of patients needs a 
different care plan and requires different pain management techniques.  
Figure 1 







The gap in nursing practice was addressed by creating an updated CPG for 
hospice clinicians to use for better pain management during hospice care. This CPG 
directs the hospice practitioners to utilize the patient’s diagnosis instead of standing 
orders for pain control, which will result in better pain management at admission. The 
expert panel and I recommend that the hospice nurses, clinicians, and practitioners use 
this updated evidence-based pain management guideline to prescribe pain medications. 
The expert panel and I recommend that the guideline move forward for review for the 
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specific approvals required by the facility at the corporate level, that the nurses be 
adequately educated and trained in the updated CPG, and that the results be monitored to 
determine the effectiveness of the guideline on quality of life and pain control. This 
updated CPG will provide prescribing information to providers so they can provide 
quality pain management and treatment to hospice patients. This will provide a better 
standard of care as well as increased quality of life and improved patient outcomes. The 
expert panel recommended that the updated CPG be incorporated into policy and added 
to the clinician's admission packet under pain management guidelines. Implementing this 
updated CPG will constitute an innovative approach using the multidisciplinary team, 
which will create a culture of improved quality of care and social change.  
This CPG adoption will help nurse practitioners and physicians provide early 
adequate pain management that will address the patients' needs by using their diagnosis 
as a guide, incorporated with standard pain scales. The project plan is for the proposed 
CPG update to be introduced to the facility administration for implementation to the local 
facility, as well as, potentially, other hospice facilities. 
Strengths and Limitations of the Project 
This updated CPG's positive aspects include that the expert panel of hospice 
clinicians were already familiar with the need for updated pain guidelines. This gave the 
clinicians a chance to incorporate their research findings into recommendations for the 
CPG update. Having the expert panel of devoted and qualified professionals ready to 
participate made the transitions from research to creation smooth. These 
recommendations strengthened the updated CPG and incorporated these suggestions into 
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a strong clinical guide. Another strength of this project is the opportunity for it to be 
applied to any clinical environment that care for hospice patients. There are many 
hospices in each state. Some of these are incorporated into home care, hospitals, and 
nursing homes. If these facilities adopt this updated CPG, the continuity of care across 
the spectrum for these patients would be seamless. Many times, hospice patients are 
moved to different facilities outside of their home area. By getting this updated CPG 
adopted in multiple areas, or potentially multiple states, this would make for a pain free 
transition. There is always a need for better pain management, especially at the end of 
life. This updated CPG would benefit any hospice location and provide much needed 
guidance for the patients we serve. This updated CPG provides a pathway of appropriate 
pain management for any provider in any location. An additional strength to the project is 
its alignment to the current changes in the healthcare delivery system. The worldwide 
interest in the development and implementation of patient-centered model of care, 
management of pain, and incorporation of evidence into practice to improve patient care 
outcomes and quality of life in hospice.  
Limitations I faced while preparing this updated CPG were the facility COVID 
restrictions. This made it difficult to meet with the clinical team and expert panels at the 
same time. Many work arounds had to be made to facilitate the meetings, suggestions, 
questions, and concerns about the CPG. It also made it difficult to gain access to the 
facility at times, to perform research in a timely manner. Another limitation was that 
since the patients are hospice patients, and most are at the end of life, supporting 
documentation for pain management was found to be lacking. This is mainly due to the 
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patient's life expectancy was shorter than traditional patients due to the nature of the 
specialty. There was also no CPG that clearly addressed pain management based on 
patients' diagnosis at admission, that I could refer to. Further, misuse of techniques by 
nursing staff due to inadequate monitoring and training in pain assessments can 
negatively affect the outcomes of the project. This happens when you have new staff or 
temporary staff nurses who are not consistent with their assessment or reporting 
techniques, such as travel nurses in nursing facilities.  
Contribution of the Doctoral Project Team 
An expert panel was assembled for review and assessment of the updated CPG. 
This panel included experts in the hospice industry and include two hospice medical 
directors, two hospice nurse practitioners and one clinical nurse specialist. These 
panelists are responsible for monitoring and prescribing the pain management regimens 
in the hospice population. The purpose of this project was to develop an evidence-based 
pain management updated clinical practice guideline to be used in the hospice 
setting. The expert panel reviewed the CPG using the Agree II tool. Domains 1 through 6 
were reviewed and applied to the tool. Under each domain, all members of the team 
strongly agreed with the recommendations. This project was fully supported by the five 
members of the panel. The nursing staff and other clinical staff including the nursing 
director and supervisors, also reviewed the project and are fully supportive of the project 




The updated CPG development for pain management was addressed in this 
section. The main strength of this project was an ability to research and define relevant, 
up to date, peer reviewed literature which was utilized to update the CPG. These research 
findings were provided by the expert panelists who are one of the main stakeholders in 
this CPG. The main limitation of this study was a lack of previous CPG's which 
addressed the need of pain management guidelines based on diagnosis. The expert panel's 
AGREE II evaluation recognized the quality and appropriateness of the updated CPG, 
which was recommended for implementation at the facility and regional level. Besides a 
reduction in the health care costs, proper pain management programs assist with 
decreasing demand on healthcare services. Effectiveness in pain management can 
promote quality of life, improved understanding of pain mechanisms, and exposure to 
different treatment options available for managing end-of-life pain. In section 5, I will 
address my plan for dissemination as well as the analysis of myself.  
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Section 5: Dissemination Plan 
The plan is for the newly updated CPG for pain management for hospice patients 
to be introduced to facility administration for review and implementation. There is more 
than one location that could benefit from implementing this CPG. Once it proves 
successful at the pilot location; it can be transferred for use to the other locations in and 
out of the state. My hope is that once it shows success, this updated CPG will be adopted 
by other hospice offices, nursing homes, and hospice in-patient facilities. This will 
provide seamless care for all patients, regardless of their acuity level, state of residence, 
or diagnosis. My plan for dissemination beyond the target location is to have the updated 
CPG published to a respectable journal such as Walden University’s Journal of 
Excellence in Nursing Healthcare Practice or the American Journal of Hospice and 
Palliative Medicine. The American Hospice journal has a robust platform with a 
population of professional nurses, advanced practice nurses, and hospice physicians who 
work in the field of hospice care where pain management is priority.  
Analysis of Self 
I started my nursing career as a licensed practical nurse in Pittsburgh, 
Pennsylvania. I found my passion in geriatric care almost immediately. Most of my 
tenure as a new nurse was on the front lines in skilled nursing, where I had many hospice 
patients. I found it my obligation to learn more about managing elderly patients so I could 
provide the best care possible. This sense of duty led to the completion of registered 
nursing education as an associate degree nurse (ADN). I knew if I were to continue my 
pursuit of being an advanced practice nurse, I needed to have more education and a better 
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foundation. I then decided to go on for my bachelor’s in nursing. I found this was still not 
enough to be in a position of advanced leadership where I could make a difference in 
nursing practice and patient care. I worked my way up in the clinical setting from a 
bedside nurse to a nurse manager to a director of clinical care to director of nursing. I had 
my sights set on being a chief nursing officer and knew I again needed to advance my 
nursing education. To teach one day, I started the Master of Nursing Education program 
and graduated from Walden University. I immediately enrolled in the DNP program 
where I am today. I have completed my lifelong dream of having a terminal degree in 
nursing and am the first nurse in my family to have such a title. Nursing is my passion; I 
love being a leader, a clinician, and a patient advocate. I love being in a position where I 
can make a difference in patient care by having influence in policy. Working toward a 
DNP taught me how to research and apply evidence into policy creation for staff, 
patients, and practitioners. Choosing to update a CPG, I found that I could give the art of 
evidence-based pain management back to the field and patient population I love.  
As a Practitioner 
As an advanced practice nurse working both at the beside and as a nursing 
director, I was able to see firsthand the practice problem and gap in nursing practice. My 
drive to continue bedside clinical practice has allowed me to understand the issues 
needing attention in the practice specialty. As an advanced practice nurse, I have worked 
with diverse hospice patient populations with different diagnoses requiring pain 
management. Early pain management techniques enable the patient and family to have an 
increased quality of life and better outcomes. After the experiences that this CPG has 
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provided, it is very clear that nurse and physician education in the art of pain 
management is essential. There is a lack of DNP prepared hospice nurses in this 
specialty, and most of those do not work directly in patient care. By utilizing the 
education that my DNP has provided me, I will be able to serve my patients firsthand 
both at the bedside and at the policy level.  
As a Scholar 
The DNP project has provided to me the tools and insight to provide 
demonstrated knowledge focused on a particular field. The DNP project plays a very 
important role in terminal education and encourages the student to be involved in 
academic and clinical practice through research. This project set a path for me to continue 
to contribute to the nursing profession through research and development. I intend to 
continue scholarly contributions to the nursing profession as my career grows so that I 
can share my knowledge of clinical and academia practices with my health care team. 
The DNP essentials that provided my platform and knowledge base for the DNP project 
will continue to mold my scholarly thinking and future contributions to nursing practice.  
As a Project Manager 
As the project manager for the updated CPG, I was fortunate to be able to 
collaborate with a dedicated and compassionate group of experts who offered their 
invaluable insight and expertise. Their recommendations on the CPG helped to guide me 
in the right direction and provide a more detailed and focused update for hospice pain 
management. I found that this expert panel was excited to assist and complete the 
AGREE II tool. It was my responsibility for providing the expert panel with the tools to 
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complete this task, such as the AGREE II instrument, the CPG, the Literature review 
matrix, and the panelist disclosure form. As the project manager, I was able to 
successfully manage these tasks. The expert panelists, who are all hospice clinicians, 
were excited to have an updated CPG tailored to their specialty. This project had its 
stressful points, but I have found it very rewarding. Knowing that the end results will be 
implemented to reduce pain in fragile hospice patients and increase their remaining 
quality of life made everything worthwhile. 
Challenges, Solutions, and Insights Gained 
During this project, I faced both personal and academic challenges. Time 
management and procrastination seemed to always be an issue, especially with the added 
challenge of COVID to my practicum setting. Challenges were further exaggerated with a 
full-time nursing manager position and a family with a very active schedule. The 
academic trials I faced were using the research tools that were new to me. AGREE II was 
also a new tool that I had to learn to use and score based on its design. My mentor was 
very helpful in motivating me in the right direction and pushing me to completion. I knew 
when I was at a crossroads that she would be my guide. The project development process 
has increased my understanding of research and helped to mold my competency in 
translating theory into research and evidence. It was through being mentored for this 
guideline that I also learned how to mentor others who were new to EBP theory. With my 
educational advancements, I can continue to be an agent for social change in the nursing 
field. By creating an updated CPG, I have also learned how invested a person must 




For this DNP scholarly project, I developed an updated clinical practice guideline 
that addresses pain with hospice patients. This addresses the gap in practice identified in 
Section 1, which states that hospice patients are all receiving the same standing orders for 
pain management despite their different diagnoses. This project promotes positive social 
change by allowing patients and families to focus on improving their quality of life 
during their remaining time together and not having to worry about the patient’s pain 
being managed appropriately. Because patient centered care is a priority in clinical 
practice, it is the duty of a nursing professional is to provide the best care possible for the 
patient’s condition. This updated CPG should improve quality patient care, reduce 
patients’ end-of-life pain, increase quality of life, and provide patient-centered care to this 
vulnerable population. By having this updated CPG as a guide, clinicians will be able to 
prescribe pain management on admission that is appropriate based on the diagnosis of the 
patient. This updated CPG will also serve to increase the clinical staff’s knowledge, 
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Appendix A: AGREE II Score Sheet 
 
Domain Item 











1. The overall objective(s) of the 
guideline is (are) specifically 
described. 
       
2. The health question(s) covered by the 
guideline is (are) specifically 
described. 
       
3. The population (patients, public, etc.) 
to whom the guideline is meant to 
apply is specifically described. 
       
Stakeholder 
involvement 
4. The guideline development group 
includes individuals from all the 
relevant professional groups. 
       
5. The views and preferences of the 
target population (patients, public, etc.) 
have been sought. 
       
6. The target users of the guideline are 
clearly defined. 
       
Rigor of 
development 
7. Systematic methods were used to 
search for evidence. 
       
8. The criteria for selecting the evidence 
are clearly described. 
       
9. The strengths and limitations of the 
body of evidence are clearly 
described. 
       
10. The methods for formulating the 
recommendations are clearly 
described. 
       
11. The health benefits, side effects and 
risks have been considered in 
formulating the recommendations. 
       
12. There is an explicit link between the 
recommendations and the supporting 
evidence. 
       
13. The guideline has been externally 
reviewed by experts prior to its 
publication. 
       















15. The recommendations are specific and 
unambiguous. 
       
16. The different options for management 
of the condition or health issue are 
clearly presented. 
       
17. Key recommendations are easily 
identifiable. 
       
Applicability 18. The guideline describes facilitators and 
barriers to its application. 
       
19. The guideline provides advice and/or 
tools on how the recommendations 
can be put into practice. 
       
20. The potential resource implications of 
applying the recommendations have 
been considered. 
       
21. The guideline presents monitoring and/ 
or auditing criteria. 




22. The views of the funding body have 
not influenced the content of the 
guideline. 
       
23. Competing interests of guideline 
development group members have 
been recorded and addressed. 



















2. I would recommend this guideline for 
use. 








Appendix B: Levels of Evidence 
 
Level 1 - Systematic review & meta-analysis of randomized controlled trials; clinical guidelines 
based on systematic reviews or meta-analyses 
Level 2 - One or more randomized controlled trials 
Level 3 - Controlled trial (no randomization) 
Level 4 - Case-control or cohort study 
Level 5 - Systematic review of descriptive & qualitative studies 
Level 6 - Single descriptive or qualitative study 
Level 7 - Expert opinion 
 
Modified from: 
Melnyk, B.M. & Fineout-Overholt, E. (2015). "Box 1.3: Rating system for the hierarchy of 
evidence for intervention/treatment questions" in Evidence-based practice in nursing & 
healthcare: A guide to best practice (3rd ed., p. 11). Wolters Kluwer Health. 
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Appendix C: Agree Reporting Checklist 
   AGREE Reporting Checklist 
2016 
 









DOMAIN 1: SCOPE AND PURPOSE 
1. OBJECTIVES 
Report the overall objective(s) of 
the guideline. The expected health 
benefits from the guideline are to 
be specific to the clinical problem or 
health topic. 
  Health intent(s) (i.e., prevention, 
screening, diagnosis, treatment, etc.) 
  Expected benefit(s) or outcome(s) 
  Target(s) (e.g., patient population, 
society) 
    
  
2. QUESTIONS 
Report the health question(s) 
covered by the guideline, 
particularly for the key 
recommendations. 
  Target population 
  Intervention(s) or exposure(s) 
  Comparisons (if appropriate) 
  Outcome(s) 
  Health care setting or context 
    
  
3. POPULATION 
Describe the population (i.e., 
patients, public, etc.) to whom the 
guideline is meant to apply. 
  Target population, sex, and age 
  Clinical condition (if relevant) 
  Severity/stage of disease (if relevant) 
  Comorbidities (if relevant) 
  Excluded populations (if relevant) 
    
  
DOMAIN 2: STAKEHOLDER INVOLVEMENT 
4. GROUP MEMBERSHIP 
Report all individuals who were 
involved in the development 
process. This may include 
members of the steering group, the 
research team involved in selecting 
and reviewing/rating the evidence 
and individuals involved in 
formulating the final 
recommendations.  
  Name of participant 
  Discipline/content expertise (e.g., 
neurosurgeon, methodologist) 
  Institution (e.g., St. Peter’s hospital) 
  Geographical location (e.g., Seattle, 
WA) 
  A description of the member’s role in 
the guideline development group 
    
  
o  
5. TARGET POPULATION 
PREFERENCES AND VIEWS 
Report how the views and 
preferences of the target population 
were sought/considered and what 
  Statement of type of strategy used to 
capture patients’/publics’ views and 
preferences (e.g., participation in the 
guideline development group, literature 
review of values and preferences) 
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the resulting outcomes were.   Methods by which preferences and 
views were sought (e.g., evidence from 
literature, surveys, focus groups) 
  Outcomes/information gathered on 
patient/public information 
  How the information gathered was 
used to inform the guideline 
development process and/or formation 
of the recommendations 
6. TARGET USERS 
Report the target (or intended) 
users of the guideline.  
  The intended guideline audience (e.g., 
specialists, family physicians, patients, 
clinical or institutional 
leaders/administrators)  
  How the guideline may be used by its 
target audience (e.g., to inform clinical 
decisions, to inform policy, to inform 
standards of care) 
    
  
DOMAIN 3: RIGOUR OF DEVELOPMENT 
7. SEARCH METHODS 
Report details of the strategy used 
to search for evidence.  
 
  Named electronic database(s) or 
evidence source(s) where the search 
was performed (e.g., MEDLINE, 
EMBASE, PsychINFO, CINAHL) 
  Time periods searched (e.g., January 
1, 2004, to March 31, 2008) 
  Search terms used (e.g., text words, 
indexing terms, subheadings) 
  Full search strategy included (e.g., 
possibly located in appendix) 
      
8. EVIDENCE SELECTION 
CRITERIA 
Report the criteria used to select 
(i.e., include and exclude) the 
evidence.  Provide rationale, where 
appropriate. 
 
  Target population (patient, public, etc.) 
characteristics 
  Study design  
  Comparisons (if relevant) 
  Outcomes  
  Language (if relevant) 
  Context (if relevant) 
    
  
9. STRENGTHS & LIMITATIONS 
OF THE EVIDENCE 
Describe the strengths and 
limitations of the evidence.  
Consider from the perspective of 
the individual studies and the body 
of evidence aggregated across all 
the studies. Tools exist that can 
facilitate the reporting of this 
concept.  
  Study design(s) included in body of 
evidence 
  Study methodology limitations 
(sampling, blinding, allocation 
concealment, analytical methods) 
  Appropriateness/relevance of primary 
and secondary outcomes considered 
  Consistency of results across studies 
  Direction of results across studies 
  Magnitude of benefit versus magnitude 
of harm 
  Applicability to practice context 




10. FORMULATION OF 
RECOMMENDATIONS 
Describe the methods used to 
formulate the recommendations 
and how final decisions were 
reached. Specify any areas of 
disagreement and the methods 
used to resolve them. 
 
  Recommendation development 
process (e.g., steps used in modified 
Delphi technique, voting procedures 
that were considered) 
  Outcomes of the recommendation 
development process (e.g., extent to 
which consensus was reached using 
modified Delphi technique, outcome of 
voting procedures) 
  How the process influenced the 
recommendations (e.g., results of 
Delphi technique influence final 
recommendation, alignment with 
recommendations and the final vote) 
      
11. CONSIDERATION OF 
BENEFITS AND HARMS 
Report the health benefits, side 
effects, and risks that were 
considered when formulating the 
recommendations. 
  Supporting data and report of benefits 
  Supporting data and report of 
harms/side effects/risks 
  Reporting of the balance/trade-off 
between benefits and harms/side 
effects/risks  
  Recommendations reflect 
considerations of both benefits and 
harms/side effects/risks  
      
12. LINK BETWEEN 
RECOMMENDATIONS AND 
EVIDENCE 
Describe the explicit link between 
the recommendations and the 
evidence on which they are based.  
 
  How the guideline development group 
linked and used the evidence to inform 
recommendations 
  Link between each recommendation 
and key evidence (text description 
and/or reference list) 
  Link between recommendations and 
evidence summaries and/or evidence 
tables in the results section of the 
guideline 
      
13. EXTERNAL REVIEW 
Report the methodology used to 
conduct the external review. 
 
  Purpose and intent of the external 
review (e.g., to improve quality, gather 
feedback on draft recommendations, 
assess applicability and feasibility, 
disseminate evidence) 
  Methods taken to undertake the 
external review (e.g., rating scale, 
open-ended questions) 
  Description of the external reviewers 
(e.g., number, type of reviewers, 
affiliations) 
  Outcomes/information gathered from 
the external review (e.g., summary of 
key findings) 
  How the information gathered was 
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used to inform the guideline 
development process and/or formation 
of the recommendations (e.g., 
guideline panel considered results of 
review in forming final 
recommendations) 
14. UPDATING PROCEDURE 
Describe the procedure for 
updating the guideline. 
  A statement that the guideline will be 
updated 
  Explicit time interval or explicit criteria 
to guide decisions about when an 
update will occur 
  Methodology for the updating 
procedure 
      
DOMAIN 4: CLARITY OF PRESENTATION 
15. SPECIFIC AND 
UNAMBIGUOUS 
RECOMMENDATIONS 
Describe which options are 
appropriate in which situations and 
in which population groups, as 
informed by the body of evidence.  
 
  A statement of the recommended 
action 
  Intent or purpose of the recommended 
action (e.g., to improve quality of life, to 
decrease side effects) 
  Relevant population (e.g., patients, 
public) 
  Caveats or qualifying statements, if 
relevant (e.g., patients or conditions for 
whom the recommendations would not 
apply) 
  If there is uncertainty about the best 
care option(s), the uncertainty should 
be stated in the guideline 
      
16. MANAGEMENT OPTIONS 
Describe the different options for 
managing the condition or health 
issue.  
  Description of management options 
  Population or clinical situation most 
appropriate to each option 
      
17. IDENTIFIABLE KEY 
RECOMMENDATIONS 
Present the key recommendations 
so that they are easy to identify.  
  Recommendations in a summarized 
box, typed in bold, underlined, or 
presented as flow charts or algorithms 
  Specific recommendations grouped 
together in one section 
      
DOMAIN 5: APPLICABILITY 
18. FACILITATORS AND 
BARRIERS TO APPLICATION 
Describe the facilitators and 
barriers to the guideline’s 
application.  
 
  Types of facilitators and barriers that 
were considered 
  Methods by which information 
regarding the facilitators and barriers to 
implementing recommendations were 
sought (e.g., feedback from key 
stakeholders, pilot testing of guidelines 
before widespread implementation) 
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  Information/description of the types of 
facilitators and barriers that emerged 
from the inquiry (e.g., practitioners 
have the skills to deliver the 
recommended care, sufficient 
equipment is not available to ensure all 
eligible members of the population 
receive mammography) 
  How the information influenced the 
guideline development process and/or 
formation of the recommendations 
19. IMPLEMENTATION 
ADVICE/TOOLS 
Provide advice and/or tools on how 
the recommendations can be 
applied in practice. 
 
  Additional materials to support the 
implementation of the guideline in 
practice.  
      For example: 
o Guideline summary documents 
o Links to check lists, algorithms 
o Links to how-to manuals 
o Solutions linked to barrier analysis 
(see Item 18) 
o Tools to capitalize on guideline 
facilitators (see Item 18) 
o Outcome of pilot test and lessons 
learned 
      
20. RESOURCE IMPLICATIONS 
Describe any potential resource 
implications of applying the 
recommendations.  
 
  Types of cost information that were 
considered (e.g., economic 
evaluations, drug acquisition costs) 
  Methods by which the cost information 
was sought (e.g., a health economist 
was part of the guideline development 
panel, use of health technology 
assessments for specific drugs, etc.) 
  Information/description of the cost 
information that emerged from the 
inquiry (e.g., specific drug acquisition 
costs per treatment course) 
  How the information gathered was 
used to inform the guideline 
development process and/or formation 
of the recommendations 
      
21. MONITORING/ AUDITING 
CRITERIA 
Provide monitoring and/or auditing 
criteria to measure the application 
of guideline recommendations.  
 
  Criteria to assess guideline 
implementation or adherence to 
recommendations 
  Criteria for assessing impact of 
implementing the recommendations 
  Advice on the frequency and interval of 
measurement 
      
59 
 
  Operational definitions of how the 
criteria should be measured 
DOMAIN 6: EDITORIAL INDEPENDENCE 
22. FUNDING BODY 
Report the funding body’s influence 
on the content of the guideline.  
  The name of the funding body or 
source of funding (or explicit statement 
of no funding) 
  A statement that the funding body did 
not influence the content of the 
guideline 
      
23. COMPETING INTERESTS 
Provide an explicit statement that 
all group members have declared 
whether they have any competing 
interests. 
  Types of competing interests 
considered 
  Methods by which potential competing 
interests were sought 
  A description of the competing 
interests 
  How the competing interests influenced 
the guideline process and development 
of recommendations 
      
 
From:  
Brouwers MC, Kerkvliet K, Spithoff K, on behalf of the AGREE Next Steps Consortium. The AGREE 
Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 2016;352: i1152. doi: 
10.1136/bmj. i1152.  
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Appendix E: Clinical Practice Guidelines 
 
Purpose 
            The purpose of this updated guideline is to provide pain management direction to 
the hospice clinical staff during the admission process. 
Procedure: 
• The CPG will be reviewed with all clinical staff on implementation 
• The CPG will be included in new hire orientation 
• The CPG will be included in the mandatory annual education for staff 
• The CPG will be included in the policy and procedure manual 
• The CPG will be used as a guide for prescribing pain medication to 
hospice patients being admitted for end-of-life care. 
Question 




            The CPG will be a tool to address pain management during the admission process 
………for hospice patients. 
  
Disease/Condition: 
            All Hospice patients  
 
Guideline Category: 
            Pain assessment, Pain management, Prevention of unwarranted acute pain;  
……...Treatment of acute pain and acute/chronic pain.   
 
General Guidance:    
• Avoid using confusing language, clinical terms, medical jargon 
• Make the pain assessment your priority on admissions  
• Do not delegate the pain assessment  
• Consider having the physician or other clinician with you, or on 
the phone standing by to give admission pain orders 
 
Recommendation 1: Numeric pain scale-    
The Numeric Pain Scale is to be used on all patients who can speak or respond to 
questions and can count to 10, This includes sleeping patients. It is recommended to wake 
a patient for a pain assessment to assess for proper pain management effectiveness. 
64 
 
Propper assessment and documentation on admission is important to follow any trend in 
increasing pain, so it can be managed quickly. The numeric pain scale should be utilized 
during any additional assessments if the patient remains capable of giving an appropriate 
response. 
       
Recommendation 2: Nonverbal pain scale- 
The Checklist of Non-verbal Pain Indicators (McGuire, 2016) should be utilized for 
nonverbal or non-responsive patients who cannot self-report pain. The CNPI has been 
incorporated into most electronic medical record systems in acute and hospice care due to 
its usefulness in treating patients who cannot self-report. If this pain scale is not available 
on the electronic medical record, a free printable copy is available online. Once this pain 
scale is utilized for non-responsive patients, the same scale should continue to be utilized 
during each subsequent pain assessment to ensure proper tracking of pain trends.  
 
Recommendation 3: Mild pain treatment by diagnosis 
Patients admitted with a diagnosis which would have a “mild” pain rating such as: End 
stage cardiac disease with edema less than 2+, failure to thrive, malnutrition, certain pain 
free cancers, mild dementia, other end stage disease with mild associated pain, and 
admission due to natural causes. These patients should follow pain recommendations for 
“mild” pain management. 
Acetaminophen extra strength and/or ibuprofen are recommended for mild pain, 
acetaminophen is not contraindicated in patients with severe hepatic impairment or those 
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at risk for hepatotoxicity in hospice care. Ibuprofen is not contraindicated in hospice 
patients with renal disease. Pain management takes priority at end of life. Research shows 
that older adults with moderate-to-severe dementia, arthritis and heart disease who take 
acetaminophen extra strength routinely have greater levels of general activity and social 
interaction than those taking a placebo (McGuire, 2016). All patients should have a 
breakthrough gentle opioid medication on board from time of admission. These patients 
should also utilize holistic measures for pain management such as: heat or cold therapy, 
massage, reiki relaxation, music therapy, touch therapy, aromatherapy, tens therapy and 
family presence. An adjuvant medication, such as an antiepileptic drug, antidepressant, 
muscle relaxant or anti-anxiety medications could also be useful in these patients before 
pain progresses.  
 
Recommendation 4: Moderate pain treatment by diagnosis 
Patients admitted with a diagnosis which would carry a “moderate” pain rating such as: 
End stage heart disease with 2+ pitting edema or greater, vascular dementia, Alzheimer’s 
dementia, fall with mechanical injury and no broken bones, untreatable aneurysm, 
Huntington’s disease, moderately metastasized cancers, and similar end stage diseases, 
select short acting opioids, with or without acetaminophen and a topical analgesic (for 
localized pain) are an appropriate measure for moderate pain. Opioids should be chosen 
based on pain type; potential adverse reactions; and patient preference and comorbidities. 
Opioids can be safely used for pain control in the hospice population, but risk evaluation 
and mitigation strategies must be in place to minimize potential adverse reactions and 
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maximize pain relief and quality of life. These medications should always be prescribed 
with a bowel regimen to prevent constipation and additional pain related to the bowels. 
All patients should have a moderate breakthrough opioid medication on board from time 
of admission. In cases of increasing moderate pain, an adjunct therapy should be 
considered. These patients should also utilize holistic measures for pain management 
such as: heat or cold therapy, massage, reiki relaxation, music therapy, touch therapy, 
aromatherapy, tens therapy and family presence. 
 
Recommendation 5: Severe pain treatment by diagnosis 
Patients admitted with a diagnosis which would carry a “severe” pain rating such as: 
metastasized cancers, mechanical fall with broken bones, MVA with trauma, any trauma 
patient, end stage vascular dementia, untreated hemorrhagic stroke, acute MI and other 
similar illnesses., Use a long-acting or extended-release opioid with acetaminophen, 
combined with a short-acting opioid for breakthrough pain. Provide pain medication 
immediately before bedtime to reduce the likelihood that the patient will be awakened by 
pain during the night. Provide pain medication around the clock during awake hours to 
reduce the likelihood of severe breakthrough pain. An adjuvant medication, such as an 
antiepileptic drug, antidepressant, muscle relaxant or anti-anxiety medications could also 
be useful in these patients. All opioid pain regimens should be prescribed with a bowel 
regimen to prevent constipation related pain issues. These patients should also utilize 
holistic measures for pain management such as: heat or cold therapy, massage, reiki 
relaxation, music therapy, touch therapy, aromatherapy, tens therapy and family 
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presence. Multimodal treatments are the most effective to manage severe pain and should 
be utilized in all cases where appropriate.  
 
Recommendation 6: Prevention of adverse reactions 
Opioid adverse events, such as severe constipation, nausea with or without vomiting, and 
sentinel events such as falls with or without injury can be additional sources of pain for 
our patients. Clinical staff should be proactively insuring there are protocols in place to 
reduce these risks The following strategies can help manage common opioid-induced 
adverse reactions: 
• Constipation- Initiate a bowel regimen immediately following a pain regimen. 
This includes stool softeners, stimulants and or fiber. Increased hydration and 
toileting regimen to promote defecation.  
• Nausea/Vomiting- Give pain medications with a meal or snack. Keep patients 
head of bed elevated, provide plenty of fluids, avoid noxious odors and provide 
antiemetics when needed.  
• Sedation/respiratory depression- Monitor 02 saturations, when possible, 
encourage the use of coughing and deep breathing If the patient can comply. 
Encourage repositioning and keeping the head of the bed elevated more than 40 
degrees. Implement safety and fall precautions, adjust medications only if 
absolutely needed.  Know the difference between sedation, distress, and end-of-
life processes.  
